Epcoritamab and Rituximab for First-line Follicular Lymphoma

NCT05783609 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Follicular Lymphoma
Low Grade Non-Hodgkin's Lymphoma, Adult

Interventions

DRUG: Epcoritamab
DRUG: Rituximab

Sponsor

Reid Merryman, MD

Collaborators

[object Object]
[object Object]